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Summary. Methionine-enkephalin and leucine- 
enkephalin, administered into the lateral ventricle of 
intact rats, increased the accumulation of DOPA by a 
naloxone-sensitive mechanism in different brain re- 
gions after inhibition of the aromatic L-amino acid 
decarboxylase. Because of the rapid enzymatic de- 
gradation of both enkephalins large doses (500 pg) were 
required to enhance brain catecholamine synthesis. The 
two enzyme resistant enkephalin analogues D-Ala 2- 
methionine enkephalin amide (DALA (4-256 pg) and 
FK 33-824 (0.003 - 1 pg) also increased the synthesis of 
DOPA, dose-dependently and by naloxone-sensitive 
mechanisms, but at much lower dosage level. The 
enkephalins markedly enhanced the brain tyrosine 
concentration but this effect was not antagonized by 
naloxone, probably because the enzymatic cleavage 
releases tyrosine from the administered peptides. In 
contrast, neither DALA nor FK 33-824 increased the 
brain tyrosine concentration. The formation of 5-HTP 
and the brain tryptophan concentration were also 
increased by the enkephalins, although these effects 
were not blocked by naloxone. The enkephalin anal- 
ogues, however, enhanced the formation of 5-HTP and 
the brain tryptophan concentration by naloxone- 
sensitive mechanisms. All four peptides accelerated the 
disappearance of dopamine, noradrenaline and 5- 
hydroxytryptamine after inhibition of monoamine syn- 
thesis. The results suggest that endogenous enke- 
phalins, through the activation of opiate receptors, are 
involved in the short-term regulation of central 
monoaminergic systems. 
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Introduction 
The enkephalins, methionine (MetS)-enkephalin (H- 
Tyr-Gly-Gly-Phe-Met-OH) and leucine (LeuS)-enke - 
phalin (H-Tyr-Gly-Gly-Phe-Leu-OH), are naturally oc- 
curring peptides with morphine-like pharmacological 
properties which have recently been isolated and char- 
acterized from mammalian brain (Hughes et al., 1975). 
Both pentapeptides are widely though unevently distri- 
buted in the central nervous system (Hong et al., 1977; 
Hughes et al., 1977), and their similar regional distri- 
butions closely parallel that of the opiate receptor (for a 
review see Snyder and Simantov, 1977). Moreover, they 
are subcellularly located in synaptosomal and micro- 
somal fractions (Osborne et al., 1978a) and their in 
vitro release from brain slices and synaptosomal pre- 
parations by a calcium-dependent process have been 
reported (Henderson et al., 1978; Iversen et al., 1978; 
Osborne et al., 1978b). All these observations suggest 
that the enkephalins play a neurotransmitter/ 
neuromodulator role in the central nervous system (for 
a review see Frederickson, 1977). 
It is well established that morphine and other 
narcotic analgesics modulate the brain dopamine turn- 
over by a naloxone-sensitive mechanism (Kuschinsky, 
1976). We have recently reported (Garcia-Sevilla et al., 
1978) that the acute administration of the opiate- 
receptor agonists, morphine and fl-endorphin, increase 
the synthesis of dopamine and serotonin in the brain of 
intact rats, while the opiate-receptor antagonists, na- 
loxone and naltrexone have opposite effects. These 
data suggest that the opiate receptors and their en- 
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d o g e n o u s  l igands  are i nvo lved  in  the s h o r t - t e r m  re- 
g u l a t i o n  o f  b o t h  n e u r o t r a n s m i t t e r s .  
C o n s e q u e n t l y ,  the p re sen t  i nves t i ga t i on  was  carr ied  
o u t  to assess the effects o f  the e n k e p h a l i n s  o n  b r a i n  
m o n o a m i n e  t u rnov e r .  Because  o f  the r ap i d  d e g r a d a t i o n  
o f  b o t h  M e t  5- a n d  LeuS-enkepha l i n s  by  b r a i n  pep-  
t idases  (Meek  et al., 1977; D u p o n t  et at., 1977), the  
effects o f  two me tabo l i ca l l y  s table  syn the t i c  ana logues ,  
D-Ala  2 - m e t h i o n i n e  e n k e p h a l i n  a mi d e  (Per t  et al., 1976) 
a n d  the  F K  33-824 c o m p o u n d  ( R o e m e r  et al., 1977), 
were also s tudied.  
Materials and Methods 
Animals. Male Sprague-Dawley rats weighing 200-  250 g 
(Anticimex, Stockholm, Sweden) were used. The animals received a 
standard diet with water freeIy available and were housed at 24~ 
under a 12 h lightdark cycle. 
Drugs. 3-Hydroxybenzylhydrazine HCI (NSD 1015, synthesized in 
this institute by Dr. P. Lindberg) and N-(BL-seryl)-NZ-(2,3,4 - 
trihydroxybenzyl)hydrazine (Ro4-4602 or benserazide, F. 
Hoffmann-La Roche Co., Basle, Switzerland) were dissolved in 0.9 % 
w/v NaC1 solution (saIine) and injected intraperitoneally (i. p.) Met 5- 
enkephalin, LeuS-enkephalin and D-Ala2-methionine enkephalin 
amide (DALA) (purchased from Serva Feinbiochemica, Heidelberg, 
FRG) and D-Ala 2, MePhe 4, Met(O) 5-ol-enkephalin (FK 33-824) (gift 
from Dr. Roemer, Sandoz Ltd., Basle, Switzerland) were dissolved in 
saline and injected intracerebroventricularly (i. c~v.). Naloxone (gift 
from Dr. Ferster, Endo Laboratories, Inc.) was dissolved in saline 
and injected i.p. or s. c. The time and dose schedules for injections are 
given in the Results section. Control rats always received the same 
number of injections of saline at the same time intervals as the 
experimental animals. 
Implantation of Intracerebroventricular Cannulae. A polyethylene 
cannula was permanently implanted into each lateral ventricle as 
described in detail previously (Garcia-Sevilla et al., 1978). The 
experiments were performed 2 days after the operation when the 
gross behaviour of the animals was normal. The proper position of 
the cannulae was checked at autopsy. 
Synthesis of Brain Monoamines. The in-vivo activity of tyrosine and 
tryptophan hydroxylase, rate-limiting enzymes in the synthesis of 
monoamines, were studied by measuring the accumulation of 3,4- 
dihydroxyphenylalanine (DOPA) and 5-hydroxytryptophan (5- 
HTP) within 30 rain after inhibition of the aromatic L-amino acid 
decarboxy~ase by a supramaximai dose of NSD 1015 (100mg/kg) 
(Carlsson et al., I972). The enkephalins (500 gg), DALA (4-256 gg) 
and FK 33-824 (3 n g -  1 ~g) were injected i. c.v. ; half of the dose was 
given into the right lateral ventricle followed within 1 min by the same 
amount into the left lateral ventricle (10 gl of peptide solution 
followed by 5 gl of saline into each ventricle). Control rats received 
15 ~1 of saline into each ventricle. The aim of these experiments was to 
study the effects of enkephalins and analogues on the rate of 
formation of noradrenaline, dopamine and 5-hydroxytryptamine. 
Utilization of Brain Monoamines. The utilization of noradrenaline, 
dopamine and 5-hydroxytryptamine (5-HT) was determined by the 
disappearance of the amines after inhibition of synthesis by another 
inhibitor of the aromatic e-amino acid decarboxylase, benserazide 
(800 mg/kg, i. p.) (And6n et al., 1967). Immediately after the adminis- 
tration of this inhibitor, the enkephalins (500 gg), DALA (50 gg) or 
FK 33-824 (1 l~g) were injected i.c.v, followed after 25min by a 
second dose representing 40 % of the first one (see above). Control 
animals received the same voIume of satiric. The rats were decapitated 
60min after the injection of benserazide. This experiment was 
designed to investigate the influence ofenkephatins and analogues on 
the rate of disappearance of monoamines after inhibition of synthesis. 
This disappearance rate is largely dependent on the rate of nerve 
impulse flow (And~n et al., 1969). 
Dissection of the Brain. After decapitation of the rats the brains were 
quickly removed and dissected on an ice-cold plate into the following 
parts: (1) Iimbic forebrain containing certain dopamine-rich struc- 
tures e.g. the olfactory tubercle, nucleus accumbens (medial part), 
nucleus amygdaloideus centralis and part of the paleocortex, (2) 
corpus striatum, (3) the remainder of the hemispheres including 
hippocampus (referred to as hemispheres), (4) diencephalon and (5) 
lower brain stem. Dopamine is the predominating catecholamine in 
parts (1) and (2) and noradrenaline in parts (3), (4) and (5). For details 
of dissection see Carlsson and Lindqvist (1973). The dissected brain 
parts were immediately frozen on dry ice and the parts of two brains 
were pooled, weighed and stored at - 8 0  ~ C. In the experiments of 
utilization of brain monoamines, whole brains were used for assay. 
Biochemical Assays. After thawing, the pooled brain parts or the 
whole brains were homogenized in 10ml of 0.4N perchloric acid 
containing 5rag sodium metabisulphite and 20mg EDTA (final 
volume 10.3ml). The homogenates were centrifuged at about 
t0,000g for 10min at 0~ and the supernatant purified on a strong 
cation exchange column (Dowex 50 W, X-4) (Kehr et al., 1972; Atack 
and Magnusson, 1978). The following spectrophotofluorimetric 
analysis were performed: tyrosine (Waalkes and Udenfriend, 1957), 
DOPA (Kehr et al., 1972), tryptophan (B~dard et al., 1972), 5-HTP 
(Atack and Lindqvist, 1973), dopamine (Atack, 1973), noradrenaline 
(Bertler et al., 1958; Kehr et al., 1976), 5-HT and 5-hydroxyindo- 
leacetic acid (5-HIAA) (Atack and Lindqvist, 1973). 
Statistics. One-way analysis of variance followed by t-test, using the 
within groups variance, was used. The level of significance was chosen 
as P = 0.05. 
Results 
Effects o f  the Enkephalins 
and their Synthetic Analogues DALA 
and FK 33-824 on Tyrosine Hydroxylase 
Activity in vivo 
The  i .c .v,  in j ec t ion  of  e i ther  M e t  5- a n d  Leu  5- 
e n k e p h a l i n  (500 ~g/rat)  e n h a n c e d  the f o r m a t i o n  of  
D O P A  in the b r a i n  o f  ra ts  t rea ted  wi th  the a r o m a t i c  L- 
a m i n o  acid  deca rboxy lase  i nh ib i t oL  N S D  1015 
(Tab le  1). I n  the  va r ious  b r a i n  regions ,  however ,  the  
increases  i n d u c e d  by  L e u S - e n k e p h a l i n  (35 - 65 %) were 
s igni f icant ly  h igher  t h a n  those  o f  M e t S - e n k e p h a l i n  
( 1 0 -  35 %). As  expected,  n a l o x o n e  (10 mg/kg) ,  a pure  
op ia te  r ecep to r  an t agon i s t ,  b l ocked  these increases  in  
all b r a i n  regions ,  except  in  the lower  b r a i n  s tem for 
M e t 5 - e n k e p h a l i n  (Tab le  1). The  two e n z y m e  res i s tan t  
e n k e p h a l i n  ana logues  D A L A  a n d  F K  33-824 caused  
the s ame  effect b u t  wi th  the  expected  differences in 
po tency .  Thus ,  the  i. c. v. a d m i n i s t r a t i o n  of  D A L A  ( 4 -  
256 ~tg/rat) a n d  F K  33-824 ( 0 . 0 0 3 - I  I~g/rat) s ignif-  
i can t ly  inc reased  the  synthes is  o f  D O P A  in a dose-  
d e p e n d e n t  m a n n e r  a n d  by  a na loxone - sens i t i ve  mech-  
a n i s m  (Figs.  1 a n d  2). As  the  f igures show, the log 
dose - re sponse  curves  for the  two e n k e p h a l i n  ana logues  
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Table 1. Effects of enkephalins on DOPA formation in rat brain regions. The enkephalins (500 pg/rat) were injected intracerebroventricularty 
(i. c. v.) 10 min before NSD 1015 (3-hydroxybenzylhydrazine; 100 mg/kg i.p.) and the rats were killed after another 30 min. Control rats received 
i. c. v. the same volume of saline 10 min before the NSD 1015. Naloxone (10 mg/kg) was given either s.c. and 30 min before MetS-enkephalin or 
i.p. and 60min before LeuLenkephalin. Shown are the means • S.E.M. with the number of experiments in parentheses 
Enkephalin DOPA (ng/g) 
Limbic Corpus Hemispheres Diencephalon Lower 
regions striatum brain stem 
Control 426 • 16 (8) 591 • 29 (7) 71 • 4 (8) 261 • 12 (8) 137 • 6 (8) 
MetS-enkephalin 510 • 33 (6)* 649 _+ 32 (6) 95 • 6 (6)** 292 _+ 27 (6) 170 • 9 (6)* 
MetS-enkephalin 
plus naloxone 431 _+ 14 (2) 514 + 28 (2) 77 • 2 (2) 252 • 13 (2) 213 _+ 31 (2)*** 
Leu5-enkephalin 603 + 35 (4)*** 898 _+ 44 (4)*** 117 _+ 10 (4)*** 351 _+ 16 (4)** 209 _+ 16 (4)** 
LeuS-enkephalin 
plus naloxone 361 • 29 (2) 617 • 48 (2) 72 _+ 9 (2) 236 • 15 (2) 133 • 8 (2) 
Leu 5- vs Met 5- 
enkephalin P < 0.05 P < 0.001 P < 0.05 NS P < 0.025 
Statistical significances were calculated according to one way analysis of variance followed by t-test. Differs from control: * P < 0.05; 
9 * P <  0.01; *** P <  0.001 
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Fig. 1. Dose-response curves for the effect of D-Ala2-methionine 
enkephaline amide (DALA) on DOPA accumulation in rat brain 
regions after decarboxylase inhibition. DALA was injected i.c.v. 
10min before NSD 1015 (100mg/kg, i.p.) and the rats were killed 
after another 30 min. Control rats received i.c.v, the same volume of 
saline 10 min before NSD 1015. The results are given in per cent of 
saline-treated control groups, each point comprising 2 pooled brain 
parts, Mean control values • S.E.M. (n = 14) in ng/g; limbic 
forebrain : 427 _+ 14; corpus striatum: 543 _+ 16; hemispheres : 78 +_ 2; 
diencephalon: 216 _+ 9; lower brain stem: 125 + 5. Open symbols 
represent rats pretreated with naloxone (10 mg/kg, s.c.) 30 rain before 
DALA. Lines are calculated regression lines 
s e e m  to  b e  a p p r o x i m a t e l y  l i n e a r  w i t h i n  t he  dose  r a n g e  
s t ud i ed .  S i g n i f i c a n t  c o r r e l a t i o n  coe f f i c i en t s  were  o b -  
t a i n e d  fo r  F K  33-824  (r = 0 . 8 4 - 0 . 9 6 ,  P <  0 .001)  w i t h  
the  e x c e p t i o n  o f  t he  l o w e r  b r a i n  s t e m  (Fig .  2), w h e r e a s  
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Fig.2. Dose-response curves for the effect of o-Ala2-MePhe 4- 
Met(O)Lol-enkephalin (FK 33-824) on DOPA accumulation in rat 
brain regions after decarboxylase inhibition. FK 33-824 was injected 
i.c.v. 10min before NSD 1015 (100mg/kg, i.p.) and the rats were 
killed after another 30min. Control rats received i.c.v, the same 
volume of saline 10 rain before NSD 1015. The results are given in per 
cent of saline-treated control groups, each point comprising 2 pooled 
brain parts. Mean control values _+ S.E.M. (n = 10) in ng/g; limbic 
forebrain : 378 _+ 16; corpus striatum: 507 _+ 17; hemispheres : 61 _+ 2; 
diencephalon: 239 _+ 16; lower brain stem: 131 _+ 5. Open symbols 
represent rats pretreated with naloxone (10 mg/kg, s.c.) i rain before 
FK 33-824. Lines are calculated regression lines 
fo r  D A L A  s t a t i s t i c a l  s i g n i f i c a n c e  was  r e a c h e d  o n l y  in  
the  l a t t e r  r e g i o n  ( r  = 0.65,  P < 0.01 ; Fig.  1). 
T h e  f o u r  o p i o i d  p e p t i d e s  d i f f e r e d  l a rge ly  in  p o t e n c y ,  
F K  33-824  b e i n g  a b o u t  1 0 0 -  1,000 t i m e s  m o r e  p o t e n t  
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Table2. Effects of enkephalins and synthetic analogues t>Ala2-methionine enkephalin amide (DALA) and D-AIa z, MePhe 4, Met(O)S-ol - 
enkephalin (FK 33-824) on the concentration of tyrosine in rat brain regions. The enkephalins (500 lag/rat) and the synthetic analogues DALA 
(125 lag/rat) and FK 33-824 (1 gg/rat) were injected intracerebroventricuIarly (i.c.v.) 10min before NSD 1015 (3-hydroxybenzylhydrazine; 
100 mg/kg i. p.) and the rats were killed after another 30 rain. Control rats received i. c. v, the same volume of  saline t0 rain before the NSD 1015. 
Nal oxone (10 mg/kg) was given either s. c. 30 min before MetS-enkephalin or i.p. 60 rain before LeuS-enkephalin. Shown are the means + S.E.M. 
with the number of experiments in parentheses 
Enkephalin Tyrosine (lag/g) 
Limbic Corpus Hemispheres Diencephalon Lower 
regions striatum brain stem 
Control 20,4 + 0.6 (18) 20.0 + 0.6 (18) 21.3 + 0,6 (18) 19,5 + 0.5 (18) 18.0 + 0.4 (18) 
MetS-enkephalin 38.0 _+ 1.4 (6)*** 25.6 + 1.3 (6)*** 50.2 + 3,3 (6)*** 46.7 + 4.5 (6)*** 39.3 _+ 3,7 (6)*** 
MetS-enkephalin 
plus naloxone 41,0 +_ 1.2 (2)*** 26,0 _+ 4.1 (2)* 49.2 +_ 6.9 (2)*** 51.2 _+ 3.5 (2)*** 47.3 + 4.1 (2)*** 
LeuS-enkephalin 30.4 _+ 1.9 (4) *** 22,3 _+ 2.3 (4) 36.1 _+ 4,2 (4)*** 33.6 _+ 1.6 (4)*** 29.4 + 1.7 (4)*** 
LeuS-enkephalin 
plus naloxone 29,9 + 2.3 (2)*** 21.3 + 0.2 (2) 29.8 + 2.5 (2)* 27.3 + 4.2 (2)* 24.3 _+ 1,0 (2)*** 
DALA 21.7 _+ 1.4 (5) 19,4 _+ 0.8 (5) 21.6 + 1.8 (5) 21.7 _+ 1.7 (5) 18.6 + 1.5 (5) 
FK 33-824 21,0 + 1.7 (2) 19.8 + 1.7 (2) 20.6 + 3.1 (2) 19.8 + 1.2 (2) 17,4 +_ 3,0 (2) 
Met s- vs Leu s- 
enkephalin P < 0.001 NS P < 0.001 P < 0.001 P < 0.005 
Statistical significances were calculated according to one way analysis of variance followed by t-test. Differs from control: * P < 0.05; 
9 ** P < 0.001 
than DALA in the various brain regions, and the latter 
about 100 times more potent than the enkephalins. In 
the limbic forebrain, a dopamine-rich area, 3 ng/rat 
of the FK 33-824 compound was the minimal effec- 
tive dose which significantly increased the forma- 
tion of DOPA after decarboxylase inhibition (43~; 
P <  0.001) (Fig. 2). This enkephalin analogue also 
proved active in increasing DOPA accumulation (22 ~ ;  
P < 0.05) in the limbic forebrain after systemic admin- 
istration (5 mg/kg; s.c.). Both Met s- and Leu 5- 
enkephalin markedly increased the brain tyrosine con- 
centrations in all brain regions, except in the corpus 
striatum where the effect was modest (Table 2). In the 
various brain regions the increases induced by Met s- 
enkephalin (85-140 ~) were significantly higher than 
those of LeuS-enkephalin (50-70 ~o). For both pep- 
tides this effect was not antagonized by naloxone 
(10mg/kg). In contrast to the enkephalins, neither 
DALA (125 lag/rat) nor FK 33-824 (1 gg/rat) increased 
the brain tyrosine concentration (Table 2). 
Effects of the Enkephalins 
and their Synthetic Analogues DALA 
and FK 33-824 on Tryptophan Hydroxylase 
Activity in vivo 
The i.c.v, injection of Met 5- or LeuS-enkephalin 
(500 gg/rat) enhances 5-HTP formation in several brain 
parts of rats treated with NSD 1015 (Table 3). Leu 5- 
enkephalin was ineffective in the limbic forebrain, 
corpus striatum and hemispheres, whereas Met s- 
enkephalin induced a small but significant increase 
(10-15 ~) in the two last mentioned brain regions. In 
the diencephalon and in the lower brain stem the 
enkephalins consistently increased the synthesis of 5- 
HTP and for the both peptides this effect was of the 
same magnitude (20-30~) .  Unexpectedly, the in- 
creases in 5-HTP formation induced by Met 5- and 
LeuS-enkephalin were not blocked by naloxone 
(10 mg/kg) (Table 3). 
The DALA analogue (125gg/rat) increased the 
formation of 5-HTP in the diencephalon and in the 
lower brain stem to about the same extent (20 ~), as did 
the enkephalins, but had a stronger effect than the 
natural enkephalins in the limbic forebrain, corpus 
striatum and hemispheres (20 - 60 ~o) (Table 4). Lower 
doses of DALA were ineffective in enhancing 5-HTP 
accumulation after decarboxylase inhibition (data not 
shown). The FK 33-824 compound moderately in- 
creased the synthesis of 5-HTP in various brain regions 
(10--25 ~o, Table 4). In contrast to the enkephalins the 
increases in 5-HTP formation induced by the synthetic 
analogues were completely blocked by the previous 
administration of naloxone (10 mg/kg) (Table 4). 
Table 5 shows the effects of the enkephalins and the 
synthetic analogues on tryptophan concentrations in 
the various rat brain regions. The increases induced by 
Mer and LeuS-enkephalin (15-50~)  were at most 
partially blocked by naloxone (10mg/kg), whereas 
those induced by DALA (20 ~) were blocked by the 
opiate receptor antagonist. The FK 33-824 compound 
did not increase the tryptophan concentrations in any 
brain region, except in the limbic forebrain (17~o; 
P < 0.05) (Table 5). 
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Table 3. Effects of enkephalins on 5-hydroxytryptophan (5-HTP) formation in rat brain regions. The enkephalins (500 lag/rat) were injected 
intracerebroventricularly (i.c.v.) 10 min before NSD 1015 (3-hydroxybenzylhydrazine; /00 mg/kg i.p.) and the rats were killed after another 
30 rain. Control rats received i. c. v. the same voiume of saline 10 rain before the NSD 1015. Naloxone (10 mg/kg) was given either s.c. and 30 rain 
before MetS-enkephalin or i.p. and 60min before LeuS-enkephalin. Shown are the means • S.E.M. with the number of experiments in 
parentheses 
Enkephalin 5-HTP (ng/g) 
Limbic Corpus Hemispheres Diencephalon Lower 
regions striatum brain stem 
Control 98 • 5 (8) 55 • 2 (8) 49 _+ 2 (8) 135 • 7 (8) 167 _+ 4 (8) 
MetS-enkephalin 108 + 9 (6) 64 + 2 (6)** 55 • 2 (6)* 163 • 7 (6)** 208 • 4 (6)*** 
MetS-enkephalin 
plus naloxone 105 _+ 2 (2) 66 _+ 2 (2)* 65 _+ 1 (2)*** 168 • 5 (2)* 210 _+ 4 (2)*** 
Leu<enkephalin 106 _+ 2 (4) 59 • 2 (4) 51 • 2 (4) 175 -+ 4 (4)** 199 +_ 9 (4)*** 
Leu<enkephaiin 
plus naloxone 112 -+ 3 (2) 53 -+ 5 (2) 61 _+ 0 (2)** 169 + 7 (2)* 189 + 1 (2)* 
Statistical significances were calculated according to one way analysis of variance followed by t-test. Differs from control: * P <  0.05; 
9 * P < 0.01 ; *** P < 0.001 
Table 4. Effects of enkephalin analogues m-Ala<methionine enkephalin am• (DALA) and l>Ala 2, MePhe 4, Met(O)<ol-enkephalin (FK 33- 
824) on 5-hydroxytryptophan (5-HTP) formation in rat brain regions. DALA (125 lag/rat) and FK 33-824 (pooled data from 0.01, 0.1, 0.3 and 
1 Ixg/rat) were injected intracerebroventricularly (i. c.v.) 10 min before NSD 1015 (3-hydroxybenzylhydrazine, 100 mg/kg i.p.) and the rats were 
killed after another 30 min. Control rats received i. c. v. the same volume of saline 10 min before NSD 1015. Naloxone (10 mg/kg) was given either 
i.p. and 60 min before DALA or s.c. and 1 min before FK 33-824 (0.1 tJg/rat). Shown are the means _+ S.E.M. with the number of experiments in 
parentheses 
Enkephalin 5-HTP (ng/g) 
Limbic Corpus Hemispheres Diencephal on Lower 
regions striatum brain stem 
Control 89 + 4 (16) 49_+ 3 (16) 48 +_2 (16) 126 + 4 (16) 147_+ 3 (16) 
DALA 109 _+ 12 (6)* 79 +_ 6 (6)*** 63 • 6 (6)** 155 + 14 (6)** 178 _+ 12 (6)*** 
DALA plus naloxone 95 + 3 (2) 57 +- 8 (2) 51 _+ 6 (2) 129 +- 1 (2) 162 +- 6 (2) 
FK33-824 100+ 4(8) 62+_4 (8)* 59_+4 (8)* 136_+ 4(8) 164+_ 4(8)* 
FK 33-824 plus 
naloxone 81 +_ 23 (2) 47 +_ 7 (2) 45 +_ 4 (2) 117 • 5 (2) 150 • 3 (2) 
Statistical significances were calculated according to one way analysis of variance followed by t-test. Differs from control: * P<  0.05; 
9 * P < 0.01 ; *** P < 0.001 
Effects of the Enkephalins 
and their Synthetic Analogues DALA 
and FK 33-824 on the Utilization 
of Dopamine, Noradrenaline and 5-HT 
Afte r  i n h i b i t i o n  o f  m o n o a m i n e  synthes is  by  benser -  
azide, b o t h  M e t <  a n d  L e u < e n k e p h a l i n  s igni f icant ly  
accelera ted  the d i s a p p e a r a n c e  of  d o p a m i n e  a n d  had  a 
s imi la r  t h o u g h  smal l  a n d  s ta t is t ical ly  n o n s i g n i f i c a n t  
effect o n  n o r a d r e n a l i n e .  L e u < e n k e p h a l i n  inc reased  the 
u t i l i za t ion  o f  d o p a m i n e  to  a larger  ex ten t  t h a n  d id  
M e t 5 - e n k e p h a l i n  ( 3 4 ~  vs. 18 ~ ;  P < 0.025). F o r  b o t h  
op io id  pept ides  the s igni f icant ly  acce lera ted  d isap-  
p e a r a n c e  o f  5 - H T  was a c c o m p a n i e d  by  s i m u l t a n e o u s  
increases  in  5 - H I A A  b r a i n  levels (Tab le6 ) .  S imi la r  
resul ts  were o b t a i n e d  wi th  the syn the t ic  ana logues  
D A L A  a n d  F K  33-824 b u t  at  m u c h  lower  dosage  level. 
In  con t r a s t  to the e n k e p h a l i n s  these a n a l o g ues  sig- 
n i f i can t ly  acce lera ted  the d i s a p p e a r a n c e  o f  n o r a d r e n -  
al ine.  The  F K  33-824 c o m p o u n d  did  n o t  accelerate  the 
u t i l i za t ion  of  5 - H T  b u t  inc reased  the 5 - H I A A  b r a i n  
levels (Tab le  6). 
Behaviour of the Animals 
Both  the e n k e p h a l i n s  (500 Ixg/rat) a n d  their  syn the t ic  
ana logues  D A L A  ( 4 - 2 5 0 t x g / r a t )  a n d  F K  33-824 
(0.003 - 1 ~tg/rat) i n d u c e d  a very s imi lar  m o r p h i n e - l i k e  
b e h a v i o u r a l  pa t t e rn ,  b u t  wi th  m a r k e d  differences in 
p o t e n c y  for the d i f ferent  c o m p o u n d s .  The  i .c.v,  in- 
j ec t ions  o f  these pept ides  caused  a loss o f  b o t h  the 
co rnea l  a n d  the eyel id  reflexes, e x o p h t a l m u s ,  ana lges ia  
(loss o f  t a i l -p inch  reflex), sa l iva t ion ,  ca ta lepsy  (ak in-  
esia) a n d  ca ta{on ia  (m uscu l a r  h y p e r t o n u s ) .  T h e y  also 
caused  acu te  episodes  o f  we t -dog  shak ing  b e h a v i o u r  
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TableS. Effects of enkephalins and synthetic analogues D-Ala2-methionine enkephalin amide (DALA) and I>Ala 2, MePhe 4, Met(O)<ol- 
enkephalin (FK 33-824) on the concentration oftryptophan in rat brain regions. The enkephalins (500 lag/rat) and the synthetic analogues DALA 
(125 gg/rat) and FK 33-824 (pooled data from 0.03, 0.1, 0.3 and I gg/rat) were injected intracerebroventricularly (i. c. v.) 10 min before NSD 1015 
(3-hydroxybenzylhydrazine; 100 mg/kg i. p.) and the rats were killed after another 30 rain. Control rats received i. c. v. the same volume of saline 
10 min before the NSD 1015. Naloxone (10 mg/kg) was given either s.c. 30 rain before Met 5-enkephalin or i. p. 60 rain before Leu s-enkephalin or 
DALA. Shown are the means _+ S.E.M. with the number of experiments in parentheses 
Enkephalin Tryptophan (lag/g) 
Limbic Corpus Hemispheres Diencephalon Lower 
regions striatum brain stem 
Control 4.6 + 0.1 (20) 4.7 + 0.1 (20) 4.7 + 0.1 (20) 4.9 + 0.1 (20) 4.4 _+ 0.1 (20) 
Met<enkephalin 5.6_+0.2 (6)** 5.2-+0.2 (6) 6.6_+0.3 (6)*** 6.7_+0.4 (6)*** 6.4+0.4 (6)*** 
MetS-enkephalin plus 
naloxone 4.6 _+ 0.6 (2) 5.3 _+ 0.2 (2) 5.0 + 0.6 (2) 5.8 + 0.4 (2) 6.4 _+ 0.4 (2)*** 
LeuS-enkephalin 6.0 _+ 0.2 (4)*** 5.4 + 0.2 (4)* 5.9 _+ 0.2 (4)** 6.7 -+ 0.2 (4)*** 5.8 _+ 0.1 (4)*** 
Leu<enkephalin plus 
naloxone 5.3 _+ 0.1 (2) 4.7 -+ 0.3 (2) 5.8 _+ 0.2 (2)* 6.1 +_ 0.4 (2)* 5.5 + 0.4 (2)* 
DALA 5.6_+0.6 (6)** 5.7+_0.5 (6)*** 5.7_+0.7 (6)** 6.0_+0.7 (6)** 5.4-+0.5 (6)*** 
DALA plus naloxone 4.8_+0.2 (2) 5.3+_0.1 (2) 5.5_+0.3 (2) 5.3_+0.6 (2) 4.6-+0.5 (2) 
FK 33-824 5.4_+0.2 (8)* 5.0_+0.1 (8) 5.3+0.1 (8) 5.4_+0.1 (8) 4.5_+0.2 (8) 
Statistical significances were calculated according to one way analysis of variance followed by t-test. Differs from control: * P < 0.05; 
9 * P <  0.01; *** P <  0.001 
Table6. Effects of enkephalins and synthetic analogues D-Ala2-methionine enkephalin amide (DALA) and I>Ala 2, MePhe r Met(O)<ol- 
enkephalin (FK 33-824) on monoamine and 5-hydroxyindoleacetic acid (5-HIAA) levels in whole rat brain after synthesis inhibition, All rats 
received benserazide (800 mg/kg, i.p.) and immediately afterwards the enkephalins (500 lag/rat) or the synthetic analogues DALA (50 lag/rat) and 
F K  33-824 (1 gg/rat) were injected intracerebroventricularly (i. c.v.) (half of the dose into each lateral ventricle) followed within 25 rain by the 
40 ~ of the first dose (half of the dose into each lateral ventricle). The animals were killed 60 min after benserazide. Control rats received i. c. v. the 
same volume of saline after pretreatment with benserazide as above. Shown are the means (ng/g) _+ S.E.M. of 4 - 5  determinations 
Enkephalin Dopamine Noradrenaline 5-HT 5-HIAA 
Control 583 _+ 32 294_+ 28 220 _+ 9 112 _+ 3 
MetS-enkephalin 476 _+ 22* 238 _+ 15 196 _+ 8* 167 + 21 * 
LeuS-enkephalin 386 _+ 21 *** 241 _+ 12 187 _+ 5 ** 139 • 2 
Control 502 _+ 21 233 + 7 178 _+ 3 124 + 6 
DALA 375 +22"** 176+_ 15"* 155_+ 6* 131 + 5 
FK33-824 394_+ 13"* 190+ 5* 186+7 149_+ 9* 
Differs from the respective control: * P < 0.05; ** P < 0.01; *** P < 0.001 (one way analysis of variance followed by t-test) 
a n d  especial ly  after  large doses o f  D A L A  (125 I~g/rat) 
r o t a t i o n a l  b e h a v i o u r  (bar re l  ro t a t ion ) .  F o r  the two syn-  
thet ic  ana logues  this b e h a v i o u r a l  p a t t e r n  was long-  
l a s t ing  (more  t h a n  40 rain).  As  a l r eady  m e n t i o n e d  the 
differences in  p o t e n c y  were very s t r ik ing ;  even  a dose as 
low as 3 n g / r a t  o f  the  F K  33-824 c o m p o u n d  clearly 
i n d u c e d  a loss o f  the co rnea l  reflex, e x o p h t a l m u s ,  
p i loe rec t ion  a n d  ca ta lep t ic  pos tu re s  in  some  o f  the rats. 
I t  shou ld  be m e n t i o n e d  tha t  F K  33-824, the  m o s t  p o t e n t  
o p i o i d  pep t ide  s tudied ,  caused  the same  b e h a v i o u r a l  
p a t t e r n  also af ter  sys temic  a d m i n i s t r a t i o n  ( 5 m g / k g ;  
s.c.). N a l o x o n e  ( l m g / k g ;  s.c.) was  able  n o t  on ly  to 
p r e v e n t  b u t  also to reverse w i th in  2 ra in  all the fully 
deve loped  b e h a v i o u r a l  m a n i f e s t a t i o n s  i n d u c e d  by  a 
large dose o f  D A L A  (250 gg / ra t ;  i .c .v.) .  
Discussion 
The  i n t r a c e r e b r o v e n t r i c u l a r  a d m i n i s t r a t i o n  o f  M e t  5- 
a n d  L e u < e n k e p h a l i n  or  their  m o r e  s table  ana logues  
D A L A  a n d  F K  33-824 s t imu la t ed  the synthesis  o f  
d o p a m i n e ,  n o r a d r e n a l i n e  a n d  5 - h y d r o x y t r y p t a m i n e  by  
na loxone - sens i t i ve  m e c h a n i s m s ,  a n d  their  u t i l i za t ion  
af ter  i n h i b i t i o n  o f  synthesis .  Therefore ,  it is t e m p t i n g  to 
conc lude  tha t  e n d o g e n o u s  enkepha l in s ,  t h r o u g h  the 
ac t iva t ion  of  op ia te  receptors ,  are i nvo lved  in the shor t -  
t e r m  r egu l a t i on  of  cen t ra l  m o n o a m i n e r g i c  systems. 
F u r t h e r  ev idence  is p r o v i d e d  by  the fact tha t  the acute  
a d m i n i s t r a t i o n  o f  the pu re  op ia te  receptor  an tagon i s t s ,  
n a l o x o n e  a n d  na l t r exone ,  decreased  the b r a i n  dopa -  
m i n e  a n d  5 - h y d r o x y t r y p t a m i n e  synthesis  (cf. Ga rc i a -  
Sevil la  et al., 1978). 
The  e n k e p h a l i n s  a n d  their  syn the t ic  ana logues  
D A L A  a n d  F K  33-824 e n h a n c e d  the f o r m a t i o n  o f  
D O P A  by  a na loxone - sens i t i ve  m e c h a n i s m ,  b o t h  in  the 
d o p a m i n e -  a n d  n o r a d r e n a l i n e - r i c h  areas  of  the b ra in .  
These  resul ts  c o n f i r m  a n d  ex t end  recen t  f ind ings  show-  
ing a na loxone - sens i t i ve  increase  in  the synthesis  o f  
d o p a m i n e  in  the cauda t e  nuc l eus  after  the i .c .v,  in- 
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jection of DALA (Biggio et al., 1978). As expected, the 
opioid peptides showed marked differences in potency 
in stimulating brain catecholamine synthesis. It has 
been reported that the breakdown of both Met 5- and 
Leu 5-enkephalin by brain peptidases is entremely rapid 
(Meek et al., 1977; Dupont et al., 1977), which, in turn, 
may account for the relatively large doses (500 lag/rat) 
needed for behavioural and biochemical effects. 
However, the low potency of the enkephalins can be 
increased after chemical manipulation of the Met 5- 
enkephalin molecule. The replacement of glycine 2 by I> 
alanine and amidation of the C-terminal carboxyl 
group (DALA), or the replacement of glycine z by D- 
alanine together with N-methylation of the phenyl- 
alanine residue and the transformation of the me- 
thionine to methioninol sulphoxide (FK 33-824), pro- 
tect against peptidase activity (Pert et al., 1976; Roemer 
et al., 1977) and the resulting enkephalin analogues 
show a considerable increase in potency. Thus, the 
analogues DALA and FK 33-824 were 102-105 times 
more potent than the enkephalins in stimulating ty- 
rosine hydroxylase activity in vivo. This neurochemical 
effect of the enkephalins was particularly striking in the 
dopamine-predominant parts of the brain, i.e. the 
limbic forebrain and the corpus striatum, where the 
doses of FK 33-824 required to increase the formation 
of DOPA were in the nanogram range (see Fig. 2). This 
extremely potent enkephalin analogue proved active 
also after systemic administration in agreement with 
published data (Roemer et al., 1977), indicating that the 
modification of the MetS-enkephalin molecule also 
enables penetration through the blood-brain barrier. 
Both Met 5- and LeuS-enkephalin markedly increased 
the brain tyrosine concentration but this effect was not 
antagonized by naloxone, indicating that opiate re- 
ceptors were not involved. It is unlikely that such an 
unspecific effect accounts for the specific increases (i. e. 
blocked by naloxone) in catecholamine synthesis in- 
duced by the enkephalins. In fact, it has been reported 
that the first step in the enzymatic breakdown of 
enkephalins is the split of the Tyr-Gly amide bond, 
releasing free tyrosine (Meek et al., 1977; Dupont et al., 
1977). The tyrosine released from the administered 
peptide might well explain the marked increases in 
brain tyrosine observed here and by others (Calderini et 
al., 1978) and the lack of antagonism by naloxone. In 
support of this possibility it was found that the two 
enzyme resistant analogues DALA and FK 33-824 did 
not increase the brain tyrosine concentration (see 
Table 2). In the various brain regions, the increases in 
tyrosine concentrations induced by MetS-enkephalin 
(85 - 140 ~)  were higher than those of LeuS-enkephalin 
(50-70  ~ suggesting that the former peptide was 
more rapidly inactivated by enzymatic cleavage, which 
may explain its lower activity on DOPA formation (see 
Tables 1 and 2). 
It has recently been reported that MetS-enkephalin 
decreases both the brain dopamine and noradrenaline 
turnover, while the synthetic analogue DALA increases 
that of dopamine without affecting noradrenaline 
turnover (Calderini et al., 1978). As discussed by these 
authors, however, the decrease in the catecholamine 
turnover induced by MetS-enkephalin might be an 
artifact involving an isotopic dilution effect, since the 
measurement of the changes in turnover were based on 
the apparent conversion of 3H-tyrosine into dopamine 
and noradrenaline during a simultaneous increase in 
brain tyrosine concentration induced by the peptide. 
When this difficulty was circumvented by measuring 
the accumulation of DOPA after decarboxylase in- 
hibition, we found that both MetS-enkephalin and 
DALA increased catecholamine synthesis and metab- 
olism independently of the brain tyrosine concen- 
tration. 
The enkephalins also enhanced the formation of 5- 
HTP and the brain tryptophan concentration, but these 
effects were at most only partially blocked by naloxone. 
Therefore, the possibility that the simultaneous in- 
creases in tryptophan concentration may secondarily 
affect the synthesis of 5-HT has to be considered. 
However: we cannot discard a stimulating action of the 
enkephalins on 5-HT neurons as indicated by the 
enhanced depletion after inhibition of synthesis by 
benserazide. In contrast to the enkephatins, the DALA 
analogue increased the accumulation of 5-HTP and the 
concentration of cerebral tryptophan by naloxone- 
sensitive mechanisms. As the utilization of 5-HT was 
also accelerated, a specific effect on serotoninergic 
neurons seems to be involved. However, a compara- 
tively large dose of DALA (125 lag/rat) was needed to 
enhance brain 5-HT turnover. Since DALA stimulated 
the formation of DOPA at a much lower dosage level 
(4 lag/rat) a more selective action of the enkephalins on 
catecholaminergic neurons can be suggested. 
The gross behavioural profiles induced by the 
enkephalins and synthetic analogues showed a close 
similarity with those induced by morphine and other 
opiated (Garcia-Sevilla et al., 1978; Browne et al., 
1979), suggesting the involvement of common mech- 
anisms. However, whether or not this behavioural 
pattern is correlated with the enkephalins-induced 
changes in brain monoamines remains to be elucidated. 
Finally, the neurochemical results do not give any 
indication where the opiate receptors, responsible for 
the increased monoamine synthesis, are situated. It has 
been reported, however, that the naloxone-sensitive 
stimulating effect of DALA on DOPA formation in the 
caudate nucleus persists after destruction of striatal 
dopamine receptors with kainic acid, suggesting that 
218 Naunyn-Schmiedeberg's Arch. Pharmacol. 310 (1980) 
the opiate receptors which mediate this effect are 
located on dopaminergic nerve terminals (Biggio et al., 
1978). It is known that presynaptic opiate receptors are 
involved in the regulation of transmitter release in the 
central nervous system. In fact, the existence of pre- 
synaptic inhibitory opiate receptors both in dopaminer- 
gic (Loh et al., 1976) and noradrenergic (Taube et al., 
1977) nerve terminals have been described. Therefore, it 
is possible that the observed increased monoamine 
synthesis induced by the enkephalins might be the 
compensatory mechanism for a decreased release of 
dopamine and noradrenaline induced by the opioid 
peptides. 
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